Dr. Matthew A. Gubens: The Expert Mesothelioma Oncologist

Get to Know Dr. Matthew A. Gubens and His Fight Against Mesothelioma

Dear reader, when someone is diagnosed with mesothelioma, it’s essential to find the right physician. In this article, we will introduce you to Dr. Matthew A. Gubens, a renowned and dedicated mesothelioma oncologist who has been helping patients fight this rare and aggressive cancer for years.

Through his expertise, commitment, and passion, Dr. Gubens has given hope to many mesothelioma patients and their families. He has been at the forefront of clinical research and innovation, seeking to improve mesothelioma treatments and extend the life expectancy of those affected by this disease. His contributions to the field of mesothelioma have made him one of the most respected and admired oncologists in the world.

If you or a loved one have been diagnosed with mesothelioma, please read on to discover how Dr. Gubens can help you fight this disease and improve your quality of life.

Who is Dr. Matthew A. Gubens?

Dr. Matthew A. Gubens is a medical oncologist and an assistant professor of medicine at the University of California, San Francisco (UCSF), where he specializes in thoracic malignancies, including mesothelioma.

Dr. Gubens completed his medical degree at Albert Einstein College of Medicine, followed by internal medicine residency training at the University of California, Davis. He then went on to complete a hematology and medical oncology fellowship at UCSF.

Dr. Gubens’ clinical practice and research interests focus on developing and implementing personalized treatments for patients with thoracic malignancies. He has authored numerous publications on mesothelioma, lung cancer, and other thoracic malignancies, and he is a sought-after speaker at national and international conferences.

The Impact of Dr. Gubens on Mesothelioma Treatment

Dr. Gubens’ impact on mesothelioma treatment has been significant. His research and clinical practice have contributed to the development of new treatment approaches, such as immunotherapy, that have shown promising results in improving mesothelioma patients’ outcomes.

Dr. Gubens’ research has also led to a better understanding of mesothelioma’s molecular biology, which has helped identify potential targets for new therapies.

Dr. Matthew A. Gubens’ credentials:
Medical degree: Albert Einstein College of Medicine
Internal medicine residency: University of California, Davis
Hematology and medical oncology fellowship: University of California, San Francisco (UCSF)
Assistant Professor of Medicine at UCSF
Specializes in thoracic malignancies, including mesothelioma

Frequently Asked Questions (FAQs)

1. What is mesothelioma?

Mesothelioma is a rare and aggressive cancer that affects the lining of the lungs, abdomen, or heart.

2. What causes mesothelioma?

Mesothelioma is mainly caused by exposure to asbestos, a naturally occurring mineral that was widely used in construction and manufacturing until the 1980s.

3. What are the symptoms of mesothelioma?

The symptoms of mesothelioma may include shortness of breath, chest pain, cough, fatigue, weight loss, and abdominal swelling.

4. How is mesothelioma diagnosed?

Mesothelioma is diagnosed through imaging tests, such as X-rays, CT scans, and MRIs, and tissue biopsy.

5. What are the treatment options for mesothelioma?

The treatment options for mesothelioma may include surgery, radiation therapy, chemotherapy, and immunotherapy.

6. What is immunotherapy?

Immunotherapy is a type of treatment that uses the patient’s immune system to fight cancer. It works by stimulating the immune system to recognize and attack cancer cells.

7. Can mesothelioma be cured?

Mesothelioma is a difficult cancer to cure. However, treatments have improved over the years, and some patients have achieved long-term survival and remission.

8. How long can you live with mesothelioma?

The life expectancy of mesothelioma patients varies depending on many factors, such as the stage of the cancer, the patient’s age and health, and the treatment received. On average, mesothelioma patients survive about one year after diagnosis.

9. Is mesothelioma fatal?

Yes, mesothelioma is a fatal cancer. However, early diagnosis and treatment may improve survival rates and quality of life.

10. Can mesothelioma be prevented?

The most effective way to prevent mesothelioma is to avoid exposure to asbestos. If you work in an industry that may expose you to asbestos, follow safety guidelines, and wear protective equipment.

11. How is mesothelioma staging determined?

Mesothelioma staging is determined by the extent and spread of the cancer. It’s usually assessed through imaging tests and biopsy.

12. What is the most effective treatment for mesothelioma?

There is no single most effective treatment for mesothelioma. Treatment plans are tailored to each patient’s individual needs and may include surgery, radiation therapy, chemotherapy, and immunotherapy.

13. How can I find a mesothelioma specialist like Dr. Gubens?

If you have been diagnosed with mesothelioma, ask your primary care physician for a referral to a specialist in your area. You can also search online for medical centers and hospitals that specialize in mesothelioma treatment.


Dr. Matthew A. Gubens is a leading mesothelioma oncologist who has dedicated his career to improving mesothelioma patients’ outcomes through research, clinical practice, and innovation. His contributions to the field of mesothelioma have made him one of the most respected and admired oncologists globally.

If you or a loved one are facing mesothelioma, we encourage you to seek the help of a mesothelioma specialist like Dr. Gubens. Early diagnosis and treatment may improve your prognosis and quality of life.

Thank you for taking the time to read this article. We hope it has been informative and helpful. If you have any further questions about mesothelioma or Dr. Matthew A. Gubens, please contact us.


The information in this article is for educational purposes only and is not intended as medical advice. Please consult with your healthcare provider for personalized medical advice and treatment. The authors of this article are not responsible for any damages or consequences resulting from the use of this information.